Prognostic Value of Next‐Generation Flow Cytometry Versus Dual‐Tracer PET/CT for Minimal Residual Disease Assessment in Multiple Myeloma

ABSTRACT To evaluate the comparative prognostic utility of next‐generation flow cytometry (NGF) and dual‐tracer PET/CT in measuring minimal residual disease (MRD), this prospective real‐world study enrolled 118 newly diagnosed multiple myeloma (NDMM) patients. Patients underwent post‐treatment asses...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Runfeng Zhang, Wenjia Zhu, Lili Cheng, Jianhua Du, Fujing Zhang, Qiao Yang, Huijuan Wang, Yun Leng, Miao Chen, Li Huo, Junling Zhuang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2026-06-01
Edice:	Cancer Medicine
Témata:	minimal residual disease multiple myeloma next‐generation flow cytometry positron emission computed tomography prognosis
On-line přístup:	https://doi.org/10.1002/cam4.72023
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!